Exelon target price raised to $47 from $45
EXC•BMO raised its target price for Exelon to $47 from $45.
Related News
Sionna Therapeutics participates in Guggenheim, Stifel healthcare conferences
SION•
Lyell Immunopharma to participate in Goldman Sachs, Stifel and Jefferies investor events
LYEL•
Bergeron urges Ethan Allen shareholders to elect five board nominees at Nov. 4 meeting
ETD•
CrowdStrike partners with Dynatrace to integrate cybersecurity and observability platforms
CRWD•
Xeris Biopharma appoints Menassie M. Taddese to board of directors
XERS•